Agios Pharmaceuticals Inc. buy Truist Financial Co.
Start price
24.12.25
/
50%
€23.80
Target price
24.12.26
€32.19
Performance (%)
5.88%
Price
29.05.26
€25.20
Summary
This prediction is currently active. With a performance of 5.88%, the BUY prediction by Truist_Financial_Co_ for Agios Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 24.12.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | 3.279% | 3.279% |
| iShares Core DAX® | 1.051% | 4.896% |
| iShares Nasdaq 100 | 2.414% | 11.649% |
| iShares Nikkei 225® | 4.165% | 13.991% |
| iShares S&P 500 | 0.963% | 6.365% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target raised by analysts at Truist Financial Corporation from $32.00 to $38.00. They now have a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€24.00
30.04.26
30.04.26
€30.85
30.04.27
30.04.27
5.00%
29.05.26
29.05.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.00
24.11.25
24.11.25
-
24.11.26
24.11.26
9.57%
29.05.26
29.05.26